Literature DB >> 12067772

Prevalence and screening of dyspnea interfering with daily life activities in ambulatory patients with advanced lung cancer.

Keiko Tanaka1, Tatsuo Akechi, Toru Okuyama, Yutaka Nishiwaki, Yosuke Uchitomi.   

Abstract

This study aimed to identify 1) the prevalence of "clinical dyspnea," defined here as dyspnea interfering with any daily life activities, 2) the impact of dyspnea on daily life activities, and 3) the screening ability of the Cancer Dyspnea Scale (CDS) and the Dyspnea Numeric Scale (DNS). A total of 157 outpatients with advanced lung cancer completed the two scales (CDS and DNS) along with a questionnaire about interference with daily life activities (normal work, walking, sleep, mood, relation with other people, enjoyment of life, and general activities). Over half of this population (55%) experienced "clinical dyspnea." Dyspnea interfered with not only physical domain (52%), such as walking and work, but also with psychological domain (23%), such as mood and enjoyment. Both scales were feasible for screening of clinical dyspnea. Applying a screening protocol may contribute to avoiding underestimation of clinical dyspnea and lead to appropriate interventions for it.

Entities:  

Mesh:

Year:  2002        PMID: 12067772     DOI: 10.1016/s0885-3924(02)00394-9

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  22 in total

1.  Dyspnea and panic among patients with newly diagnosed non-small cell lung cancer.

Authors:  Jennifer A Shin; Jesse D Kosiba; Lara Traeger; Joseph A Greer; Jennifer S Temel; William F Pirl
Journal:  J Pain Symptom Manage       Date:  2014-04-21       Impact factor: 3.612

2.  Practical Dyspnea Assessment: Relationship Between the 0-10 Numerical Rating Scale and the Four-Level Categorical Verbal Descriptor Scale of Dyspnea Intensity.

Authors:  Nicholas G Wysham; Benjamin J Miriovsky; David C Currow; James E Herndon; Gregory P Samsa; Andrew Wilcock; Amy P Abernethy
Journal:  J Pain Symptom Manage       Date:  2015-05-22       Impact factor: 3.612

3.  Development of a Symptom Management Intervention: Qualitative Feedback From Advanced Lung Cancer Patients and Their Family Caregivers.

Authors:  Catherine E Mosher; Mary A Ott; Nasser Hanna; Shadia I Jalal; Victoria L Champion
Journal:  Cancer Nurs       Date:  2017 Jan/Feb       Impact factor: 2.592

4.  Certain bio-psychosocial-spiritual problems associated with dyspnea among advanced cancer patients in Taiwan.

Authors:  Chih-Te Ho; Hua-Shui Hsu; Chia-Ing Li; Chiu-Shong Liu; Chin-Yu Lin; Cheng-Chieh Lin; Wen-Yuan Lin
Journal:  Support Care Cancer       Date:  2011-09-27       Impact factor: 3.603

5.  Routine dyspnea assessment on unit admission.

Authors:  Kathy Baker; Jennifer Barsamian; Danielle Leone; Barbara C Donovan; Donna Williams; Kerry Carnevale; Robert Lansing; Robert Banzett
Journal:  Am J Nurs       Date:  2013-11       Impact factor: 2.220

6.  Dyspnea during daily activities in chronic spinal cord injury.

Authors:  Noel F Grandas; Nitin B Jain; Joan B Denckla; Robert Brown; Carlos G Tun; Mary Ellen Gallagher; Eric Garshick
Journal:  Arch Phys Med Rehabil       Date:  2005-08       Impact factor: 3.966

Review 7.  Dyspnea in lung cancer patients: a systematic review.

Authors:  Ganesan Kathiresan; Reynold F Clement; Meera T Sankaranarayanan
Journal:  Lung Cancer (Auckl)       Date:  2010-11-22

8.  Tailoring Cognitive-Behavioral Therapy to Treat Anxiety Comorbid with Advanced Cancer.

Authors:  Joseph A Greer; Elyse R Park; Holly G Prigerson; Steven A Safren
Journal:  J Cogn Psychother       Date:  2010-01-01

9.  Effect of palliative oxygen versus room air in relief of breathlessness in patients with refractory dyspnoea: a double-blind, randomised controlled trial.

Authors:  Amy P Abernethy; Christine F McDonald; Peter A Frith; Katherine Clark; James E Herndon; Jennifer Marcello; Iven H Young; Janet Bull; Andrew Wilcock; Sara Booth; Jane L Wheeler; James A Tulsky; Alan J Crockett; David C Currow
Journal:  Lancet       Date:  2010-09-04       Impact factor: 79.321

10.  Effects of Oral Morphine on Dyspnea in Patients with Cancer: Response Rate, Predictive Factors, and Clinically Meaningful Change (CJLSG1101).

Authors:  Kosuke Takahashi; Masashi Kondo; Masahiko Ando; Akira Shiraki; Harunori Nakashima; Hisashi Wakayama; Kensuke Kataoka; Masashi Yamamoto; Yasuteru Sugino; Mitsunori Nishikawa; Kazuyoshi Imaizumi; Eiji Kojima; Atsushi Sumida; Yoshihiro Takeyama; Hiroshi Saito; Yoshinori Hasegawa
Journal:  Oncologist       Date:  2019-01-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.